Trial Profile
Clinical trial on the effect of bezafibrate in the muscular form of carnitine palmitoyltransferase 2 deficiency
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bezafibrate (Primary)
- Indications Lipid metabolism disorders; Rhabdomyolysis
- Focus Pharmacodynamics
- 21 Oct 2006 New trial record.